Ann: Investor Presentation, page-212

I don't think so. Trading is very thin at the moment. The share price is just as likely to jump higher.
The company has made significant progress the last 6 months and is a serious disruptor to the likes of ResMed.

The revenue for the December quarter will not be much as distribution deals are only now clicking into gear.
The quarterly should however enlighten us as to any new distribution deals and from that we can extrapolate future revenues.

Each quarter on quarter will have increasing revenues just based on contracts already entered.

The cash position will be important. Based on est Dec expenditures from the previous quarterlies it would appear that another cap raise and possibly the last will be expected sometime in the next 6 months.